Articles

Braly’s political skirmishes hurting insurer, critics say

When WellPoint Inc. named Angela Braly its CEO three years ago, it touted her experience dealing with politicians and government
regulators. But WellPoint is now the poster child for health insurer bad behavior—credited in Washington with reviving a
dead health reform bill the company opposed.

Read More

Indy firm launches bedsore weapon

The latest idea from Dr. James Spahn, an Indianapolis health care entrepreneur, should help hospitals and nursing homes do
a better job of preventing severe bedsores, or pressure ulcers. That’s good, because Medicare and private health insurers
increasingly won’t pay to treat them.

Read More

Indiana moves up in med tech rankings

Medical technology companies employed 19,950 Hoosiers in 2007 and supported another 35,000 jobs in supplier companies, according
to an analysis funded by an industry trade group.

Read More

Research reforms will force Lilly, others to test how drugs stack up

The federal government is currently doling out $1.1 billion in stimulus funds to pay for research that compares multiple medical
treatments against one another to determine which is most effective. Drug companies like Eli Lilly and Co. are wary that comparative-effectiveness
research could threaten their sales.

Read More

Study: Online doc ratings mostly positive

Angie’s List physician rating service has been controversial since it started in 2008. But an academic journal article
is now telling the docs to relax. Nearly 90 percent of patient comments on sites like Angie’s List are positive.

Read More